Related Experiment Video
Updated: Apr 28, 2026

07:19
Author Spotlight: Efficiently Eliminating Bacteriophages from Infected Salmonella Cultures Using Lipopolysaccharides
Published on: June 28, 2024
1.6K
Phage neutralization by sera of patients receiving phage therapy
Viral Immunology
|June 4, 2014
Summary
Phage therapy (PT) can induce antiphage antibodies, particularly when administered locally. This antibody induction does not necessarily impede successful PT outcomes.
Area of Science:
- Microbiology
- Immunology
- Biotechnology
Background:
- Phage therapy (PT) utilizes bacteriophages to treat bacterial infections.
- The potential for PT to induce an immune response, specifically antiphage antibodies, requires investigation.
- Understanding this immune response is crucial for optimizing PT efficacy.
Purpose of the Study:
- To determine if phage therapy (PT) induces antiphage antibodies in patients.
- To assess the impact of different phage administration routes and types on antibody induction.
- To correlate antiphage activity with PT outcomes.
Main Methods:
- Neutralization tests and enzyme-linked immunosorbent assays (ELISA) were used to measure antiphage activity in patient and volunteer sera.
- Sera were collected before, during, and after PT from 122 patients and 30 healthy volunteers.
- Phage inactivation rate (K) quantified serum neutralization capacity.
Main Results:
- Low antiphage activity was observed in healthy volunteers and before PT.
- Significant antiphage activity (high K rates) was detected in 12.3% of patients receiving local or local/oral PT, particularly with Staphylococcus aureus, Pseudomonas aeruginosa, and Enterococcus faecalis phages.
- Oral PT resulted in low antiphage activity.
- Antiphage activity generally decreased after therapy completion.
Conclusions:
- The induction of antiphage antibodies during PT is dependent on the route of administration and phage type.
- Local administration of phages is more likely to induce a detectable antiphage response.
- The presence of antiphage antibodies does not preclude a favorable outcome from phage therapy.
Related Concept Videos
Lytic Cycle of Bacteriophages
60.1K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
60.1K
Lysogenic Cycle of Bacteriophages
49.6K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
49.6K
Acute Pharyngitis
6.6K
Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
6.6K

